Generic drugs generate big return for TPG
TPG Capital, which is out fundraising, stands to make about 7.5x its money with the sale of Par Pharmaceutical Holdings Inc.
18 May 2015•2 mins read
TPG Capital, which is out fundraising, stands to make about 7.5x its money with the sale of Par Pharmaceutical Holdings Inc.
Water Street and JLL Partners’ Eversana announces acquisition of London’s Estima Scientific
1 hour ago · 1 min read
DPE’s Mehler Systems to acquire majority stake in Bulgaria’s MARS Armor
1 hour ago · 1 min read
Speyside Equity buys Midwest steel tubing and building products maker Tapco
20 hours ago · 2 mins read
BayPine-backed Relation Insurance buys assets of St. Louis’s Wright Insurance Planning
20 hours ago · 1 min read
Baird Capital’s Blue Matter announces acquisition of London healthcare communications agency Cognite
20 hours ago · 1 min read
Strategic Value Partners agrees to back NewEdge Power in battery storage JV
21 hours ago · 2 mins read
Oak Hill strikes deal to take majority stake in Wyyerd from Carlyle
22 hours ago · 2 mins read
